Can Animal Models of Disease Reliably Inform Human Studies?
article has not abstract
Vyšlo v časopise:
Can Animal Models of Disease Reliably Inform Human Studies?. PLoS Med 7(3): e32767. doi:10.1371/journal.pmed.1000245
Kategorie:
Research in Translation
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000245
Souhrn
article has not abstract
Zdroje
1. HackamDG
RedelmeierDA
2006 Translation of research evidence from animals to humans. JAMA 296 1731 1732
2. PerelP
RobertsI
SenaE
WhebleP
BriscoeC
2007 Comparison of treatment effects between animal experiments and clinical trials: systematic review. B M J 334 197
3. HackamDG
2007 Translating animal research into clinical benefit. B M J 334 163 164
4. BesselinkMG
van SantvoortHC
BuskensE
BoermeesterMA
van GoorH
2008 Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371 651 659
5. ShuaibA
LeesKR
LydenP
GrottaJ
DavalosA
2007 NXY-059 for the treatment of acute ischemic stroke. N Engl J Med 357 562 571
6. DirksenMT
LaarmanGJ
SimoonsML
DunckerDJ
2007 Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies. Cardiovasc Res 74 343 355
7. YellonDM
HausenloyDJ
2007 Myocardial reperfusion injury. N Engl J Med 357 1121 1135
8. O'CollinsVE
MacleodMR
DonnanGA
HorkyLL
van der WorpBH
2006 1,026 experimental treatments in acute stroke. Ann Neurol 59 467 477
9. Van der WorpHB
Van GijnJ
2007 Clinical practice. Acute ischemic stroke. N Engl J Med 357 572 579
10. GrottaJ
2001 Neuroprotection is unlikely to be effective in humans using current trial designs. Stroke 33 306 307
11. GladstoneDJ
BlackSE
HakimAM
Heart and Stroke Foundation of Ontario Centre of Excellence in Stroke Recovery 2002 Toward wisdom from failure. Lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 33 2123 2136
12. JuniP
AltmanDG
EggerM
2001 Systematic reviews in health care: Assessing the quality of controlled clinical trials. B M J 323 42 46
13. AltmanDG
SchulzKF
MoherD
EggerM
DavidoffF
2001 The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134 663 694
14. Stroke Therapy Academic Industry Roundtable (STAIR) 1999 Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 30 2752 2758
15. DirnaglU
2006 Bench to bedside: the quest for quality in experimental stroke research. J Cereb Blood Flow Metab 26 1465 1478
16. SenaE
Van der WorpHB
HowellsD
MacleodM
2007 How can we improve the pre-clinical development of drugs for stroke? Trends Neurosci 30 433 439
17. MacleodMR
FisherM
O'CollinsV
SenaES
DirnaglU
2009 Good laboratory practice: preventing introduction of bias at the bench. Stroke 40 e50 e52
18. RosenthalR
1966 Experimenter effects in behavioral research. New York Appleton-Century-Crofts
19. Van der WorpHB
de HaanP
MorremaE
KalkmanCJ
2005 Methodological quality of animal studies on neuroprotection in focal cerebral ischaemia. J Neurol 252 1108 1114
20. Van der WorpHB
SenaES
DonnanGA
HowellsDW
MacleodMR
2007 Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. Brain 130 3063 3074
21. CampbellMJ
JuliousSA
AltmanDG
1995 Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. B M J 311 1145 1148
22. FestingMF
AltmanDG
2002 Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR J 43 244 258
23. BathPM
MacleodMR
GreenAR
2009 Emulating multicentre clinical stroke trials: a new paradigm for studying novel interventions in experimental models of stroke. Int J Stroke 4 471 479
24. LeeDS
NguyenQT
LapointeN
AustinPC
OhlssonA
2003 Meta-analysis of the effects of endothelin receptor blockade on survival in experimental heart failure. J Card Fail 9 368 374
25. MacleodMR
Van der WorpHB
SenaES
HowellsDW
DirnaglU
2008 Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality. Stroke 39 2824 2829
26. SamaranayakeS
2009 Study Quality in Experimental Stroke. Camarades Monograph Number 2, http://www.camarades.info/index_files/CM2.pdf. (accessed 22/12/09)
27. MiettinenOS
1983 The need for randomisation in the study of intended effects. Stat Med 2 267 271
28. SchulzKF
ChalmersI
HayesRJ
AltmanDG
1995 Emperical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273 408 412
29. NoseworthyJH
ebersGC
VandervoortMK
FarquharRE
YetisirE
1994 The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. Neurology 44 16 20
30. SchulzKF
GrimesDA
2002 Blinding in randomised trials: hiding who got what. Lancet 359 696 700
31. SchulzKF
GrimesDA
2002 Allocation concealment in randomised trials: defending against deciphering. Lancet 359 614 618
32. SchulzKF
GrimesDA
2005 Sample size calculations in randomised trials: mandatory and mystical. Lancet 365 1348 1353
33. BebartaV
LuytenD
HeardK
2003 Emergency medicine animal research: Does use of randomization and blinding affect the results? Acad Emerg Med 10 684 687
34. MacleodMR
O'CollinsT
HowellsDW
DonnanGA
2004 Pooling of animal experimental data reveals influence of study design and publication bias. Stroke 35 1203 1208
35. CrossleyNA
SenaE
GoehlerJ
HornJ
van derWB
2008 Empirical evidence of bias in the design of experimental stroke studies: a metaepidemiologic approach. Stroke 39 929 934
36. Van der WorpHB
RaaijmakersTW
KappelleLJ
2008 Early complications of ischemic stroke. Curr Treat Options Neurol 10 440 449
37. SaverJL
JohnstonKC
HomerD
WitykR
KoroshetzW
1999 Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. Stroke 30 293 298
38. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group 2000 Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography. Stroke 31 2912 2919
39. KimmelmanJ
LondonAJ
RavinaB
RamsayT
BernsteinM
2009 Launching invasive, first-in-human trials against Parkinson's disease: ethical considerations. Mov Disord 24 1893 1901
40. ScottS
KranzJE
ColeJ
LincecumJM
ThompsonK
2008 Design, power, and interpretation of studies in the standard murine model of ALS. Amyotroph Lateral Scler 9 4 15
41. DwanK
AltmanDG
ArnaizJA
BloomJ
ChanAW
2008 Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One 3 e3081
42. DirxMJ
ZeegersMP
DagneliePC
van den BogaardT
van den BrandtPA
2003 Energy restriction and the risk of spontaneous mammary tumors in mice: a meta-analysis. Int J Cancer 106 766 770
43. MacleodMR
O'CollinsT
HorkyLL
HowellsDW
DonnanGA
2005 Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke. J Cereb Blood Flow Metab 25 713 721
44. JuutilainenJ
KumlinT
NaaralaJ
2006 Do extremely low frequency magnetic fields enhance the effects of environmental carcinogens? A meta-analysis of experimental studies. Int J Radiat Biol 82 1 12
45. BenatarM
2007 Lost in translation: treatment trials in the SOD1 mouse and in human ALS. Neurobiol Dis 26 1 13
46. NeitzkeU
HarderT
SchellongK
MelchiorK
ZiskaT
2008 Intrauterine growth restriction in a rodent model and developmental programming of the metabolic syndrome: a critical appraisal of the experimental evidence. Placenta 29 246 254
47. SenaES
Van der WorpHB
BathPMW
HowellsDW
MacleodMR
2010 Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PloS Biology. PLoS Biol 8(3) e1000344 doi:10.1371/journal. pbio.1000344
48. De AngelisC
DrazenJM
FrizelleFA
HaugC
HoeyJ
2004 Clinical trial registration: a statement from the International Committee of Medical Journal Editors. N Engl J Med 351 1250 1251
49. WillmotM
GibsonC
GrayL
MurphyS
BathP
2005 Nitric oxide synthase inhibitors in experimental ischemic stroke and their effects on infarct size and cerebral blood flow: a systematic review. Free Radic Biol Med 39 412 425
50. WillmotM
GrayL
GibsonC
MurphyS
BathPM
2005 A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide 12 141 149
51. GibsonCL
GrayLJ
MurphySP
BathPM
2006 Estrogens and experimental ischemic stroke: a systematic review. J Cereb Blood Flow Metab 26 1103 1113
52. GibsonCL
GrayLJ
BathPM
MurphySP
2008 Progesterone for the treatment of experimental brain injury; a systematic review. Brain 131 318 328
53. BanwellV
SenaES
MacleodMR
2009 Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke. J Stroke Cerebrovasc Dis 18 269 276
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2010 Číslo 3
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Pleiotropní účinky statinů na kardiovaskulární systém
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- Zástava srdce u pacienta se střelnými ranami – kazuistika
- Statinová intolerance
Najčítanejšie v tomto čísle
- BMI and Risk of Serious Upper Body Injury Following Motor Vehicle Crashes: Concordance of Real-World and Computer-Simulated Observations
- Unravelling the Genetics of Ischaemic Stroke
- Human Resource and Funding Constraints for Essential Surgery in District Hospitals in Africa: A Retrospective Cross-Sectional Survey
- CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials